Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Gliopathy of Demyelinating and Non-Demyelinating Strains of Mouse Hepatitis Virus
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Gliopathy of Demyelinating and Non-Demyelinating Strains of Mouse Hepatitis Virus
Creator
Das Sarma, Jayasri
Biswas, Kaushiki
Nabar, Manasi
Stout, Marjorie
Grinspan, Judith
Hingley, Susan
Kenyon, Lawrence
Shindler, Kenneth
Fernandes, Adelaide
Pizzorusso, Tommaso
Weissert, Robert
Source
PMC
abstract
Demyelination in the central nervous system induced by neurovirulent strains of Mouse Hepatitis Virus (MHV) is mediated by the viral spike glycoprotein, but it is not clear whether the mechanism of this disease pathology involves direct viral infection of oligodendrocytes. Detailed studies of glial cell tropism of MHV are presented, demonstrating that direct MHV infection of oligodendrocytes differs between demyelinating (RSA59) and non-demyelinating (RSMHV2) viral strains both in vitro and in vivo. Our results indicate that direct injury of mature oligodendrocytes is an important mechanism of virus-induced demyelination. In vivo, RSA59 infection was identified in spinal cord gray and white matter, but infected oligodendrocytes were restricted to white matter. In contrast, RSMHV2 infection was restricted to gray matter neurons and was not localized to oligodendrocytes. In vitro, RSA59 can infect both oligodendrocyte precursors and differentiated oligodendrocytes, whereas RSMHV2 can infect oligodendrocyte precursors but not differentiated oligodendrocytes. Viral spreading through axonal means to white matter and release of the demyelinating strain MHV at the nerve end is critical for oligodendrocytes infection and subsequent demyelination. Understanding the mechanisms by which known viruses effect demyelination in this animal model has important therapeutic implications in the treatment of human demyelinating disease.
has issue date
2015-12-22
(
xsd:dateTime
)
bibo:doi
10.3389/fncel.2015.00488
bibo:pmid
26733813
has license
cc-by
sha1sum (hex)
575faff450d20d0f359d000ebc8b66b638094613
schema:url
https://doi.org/10.3389/fncel.2015.00488
resource representing a document's title
Gliopathy of Demyelinating and Non-Demyelinating Strains of Mouse Hepatitis Virus
has PubMed Central identifier
PMC4686739
has PubMed identifier
26733813
schema:publication
Front Cell Neurosci
resource representing a document's body
covid:575faff450d20d0f359d000ebc8b66b638094613#body_text
is
schema:about
of
named entity 'gray'
named entity 'therapeutic'
named entity 'infection'
named entity 'Strains'
named entity 'KNOWN'
covid:arg/575faff450d20d0f359d000ebc8b66b638094613
named entity 'CLEAR'
named entity 'STUDIES'
named entity 'STRAINS'
named entity 'CRITICAL'
named entity 'IN VIVO'
named entity 'MEDIATED'
named entity 'INFECT'
named entity 'MOUSE HEPATITIS VIRUS'
named entity 'GRAY'
named entity 'DETAILED'
named entity 'VIRUS'
named entity 'STRAINS'
named entity 'NON-'
named entity 'RESULTS'
named entity 'LOCALIZED'
named entity 'SPREADING'
named entity 'DIRECT'
named entity 'DEMYELINATING DISEASE'
named entity 'INFECTION'
named entity 'VIRAL INFECTION'
named entity 'MECHANISMS'
named entity 'MOUSE HEPATITIS VIRUS'
named entity 'UNDERSTANDING'
named entity 'THERAPEUTIC'
named entity 'INJURY'
named entity 'BUT'
named entity 'OUR'
named entity 'MEANS'
named entity 'STRAIN'
named entity 'PRESENTED'
named entity 'EFFECT'
named entity 'SPINAL CORD'
named entity 'RESTRICTED'
named entity 'SUBSEQUENT'
named entity 'CENTRAL NERVOUS SYSTEM'
named entity 'DEMYELINATION'
named entity 'GRAY MATTER'
named entity 'IN VITRO'
named entity 'DIFFERENTIATED'
named entity 'VIRAL'
named entity 'INDUCED'
named entity 'IMPORTANT'
named entity 'VIRUSES'
named entity 'TROPISM'
named entity 'IDENTIFIED'
named entity 'INFECTED'
named entity 'MECHANISM'
named entity 'PRECURSORS'
named entity 'RELEASE'
named entity 'TREATMENT'
named entity 'NON-'
named entity 'OLIGODENDROCYTE'
named entity 'WHITE MATTER'
named entity 'HUMAN'
named entity 'ANIMAL MODEL'
named entity 'OLIGODENDROCYTES'
named entity 'GLIAL CELL'
named entity 'DISEASE'
named entity 'NERVE END'
named entity 'AXONAL'
named entity 'MATURE'
named entity 'CONTRAST'
named entity 'NEURONS'
named entity 'PATHOLOGY'
named entity 'contrast'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 11
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software